Which Obstacles Prevent Us from Recruiting into Clinical Trials: A Survey about the Environment for Clinical Studies at a German University Hospital in a Comprehensive Cancer Center-Reference-Cited by-同舟云学术

Which Obstacles Prevent Us from Recruiting into Clinical Trials: A Survey about the Environment for Clinical Studies at a German University Hospital in a Comprehensive Cancer Center

Published:2017-08-28 Issue: Volume:7 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Straube Christoph,Herschbach Peter,Combs Stephanie E.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference11 articles.

1. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Breast;Lancet,2015

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study;Campbell;Health Technol Assess,2007

4. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors;Mills;Lancet Oncol,2006

5. Barriers to participation in randomised controlled trials: a systematic review;Ross;J Clin Epidemiol,1999

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Recruitment System for Clinical Trials: A Mixed-Methods Study about Requirements at 10 University Hospitals (Preprint);JMIR Medical Informatics;2021-03-12

2. Towards a Patient Recruitment System for Clinical Trials: A Mixed-Methods Study about the Status Quo & User Requirements at 10 University Hospitals (Preprint);2021-03-12

3. Key components and IT assistance of participant management in clinical research: a scoping review;JAMIA Open;2020-10-01

4. The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma: ten questions;Future Oncology;2019-01

5. Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC);Clinical and Translational Radiation Oncology;2018-11